Rafe Swan/Getty Images; Dan WardIrreproducible preclinical research is a global, expensive, and well-recognized problem that contributes to delays a
Mark C. Gibson
Advertisement
Articles by Mark C. Gibson
Advertisement
Latest Updated Articles
Changing the Culture of Cell Culture: Applying Best Practices and Authentication to Ensure Scientific ReproducibilityPublished: October 1st 2015 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Considerations for Quality Improvement of Cleaning, Disinfection, and Cleaning Validation in Biopharmaceutical Manufacturing, Part II. Biopharmaceutical Non-Sterile Equipment Cleaning
2
How Big Biopharma Investment in CGTs Will Redefine the Industry Pipeline
3
Celebrating 20 Years of HPLC-CAD Technology
4
AstraZeneca Next to Agree to MFN Deal: Report
5
